Our first guests are Jodi Grant, Executive Director of the Afterschool Alliance. Barry Ford, President of the Council for a Strong America, will discuss the President’s budget proposal and its potential impact on students and families, the importance of afterschool programs and the ways they help students succeed in school and in life as well as how we can do our part to make sure every child can attend an afterschool program near them. For more information please visit www.afterschoolalliance.org
Our next guest is Dr. David Lederer, Associate Professor of Medicine and Epidemiology at Columbia University Medical Center in New York City discusses what pulmonary fibrosis is, how it is diagnosed and what to look for in a doctor or hospital to get evaluated and treated. He’ll also discuss how by understanding your potential risk factors you can work with your physician to improve the quality of your life. He will also discuss that The Pulmonary Fibrosis Foundation (PFF) has launched a new educational website to educate individuals about this deadly disease. AboutPF.org offers a downloadable Pulmonary Fibrosis Risk List worksheet to facilitate the conversation about symptoms and risk factors with a general physician. For more information please visit www.AboutPF.org
Lynnette Lee-Villanueva, AARP Foundation Vice President of Tax-Aide, Discusses Free Resources for People Looking for Tax Help State-Specific Information Available AARP Foundation Tax-Aide is the largest free, volunteer-run tax assistance and preparation program in the United States. Through April 15, 2019, the program will offer in-person tax preparation help to anyone, but especially to low- and moderate-income taxpayers and those who are 50 or older. There is no fee and AARP membership is not required.
Our third guest is Paul A. Gurbel, MD, FACC, Director of Interventional Cardiology and Cardiovascular Medicine Research and Professor of Medicine at Johns Hopkins School of Medicine. American College of Cardiology and the American Heart Association made changes to their guideline for the use of aspirin to prevent first heart attacks, strokes and heart failure, which is primary prevention. This update has led to confusion among doctors and the general public about the preventative use of aspirin.Dr. Gurbel, will discuss the changes in these guidelines and provide more information around the preventative use of aspirin. For more information, visit: www.bayeraspirin.com.
Dr. Andrew Spitzer, lead author of the U.S. based multi-center study, is co-director of the Joint Replacement Program at Cedars-Sinai Medical Center in Los Angeles, CA. He specializes in orthopedics and is board certified in Orthopedic Surgery. Dr. Spitzer received his medical degree from David Geffen School of Medicine at UCLA and has been in practice for more than 20 years. Osteoarthritis (OA), also known as degenerative joint disease, affects more than 30 million Americans and occurs when the protective cartilage on the ends of your bones wears down over time. In 2017, ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) was approved by the U.S. FDA as the first and only extended-release intra-articular therapy for people with osteoarthritis-related knee pain. It is a nonopioid therapy that employs Flexion Therapeutics’ proprietary microsphere technology to provide extended pain relief
for 12 weeks.